EMA approves a new indication of Rxulti to treat schizophrenia in adolescents
Otsuka and Lundbeck have announced that the European Commission (CE) has authorized the use of Rxulti (Brexpiprazole) for the treatment ...
Otsuka and Lundbeck have announced that the European Commission (CE) has authorized the use of Rxulti (Brexpiprazole) for the treatment ...
Schizophrenia is a complex disorder that affects perception, thought and emotions. A new study conducted by the University of Zurich ...
French police seriously injured a 17 -year -old teenager Schizophrenia and armed with two Catanas In Vitry-Sur-Seine (south of Paris), ...
02/06/2025 Updated at 12:25. The European Court of Human Rights has condemned Spain To pay a compensation of 20,000 euros ...
Schizophrenia is a serious mental disorder that affects about 1 % of the world's population. UB researchers have identified a ...
Schizophrenia is the name given to a group of mental illnesses characterized by personality alterations, hallucinations and loss of contact ...
KarXTa drug recently approved to treat schizophrenia, is generating high expectations about its potential to also treat Alzheimer's disease. This ...
It has been known for decades that the classic symptoms of schizophrenia, such as jumping to conclusions or difficulty adapting ...
Two researchers from the Santa Lucía Hospital in Cartagena participated in the first clinical study that confirms the effectiveness of ...